BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19040)

  • 1. Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification by affinity chromatography and ultraviolet difference spectrophotometric and circular dichroic studies.
    Gupta SV; Greenfield NJ; Poe M; Makulu DR; Williams MN; Moroson BA; Bertino JR
    Biochemistry; 1977 Jul; 16(14):3073-9. PubMed ID: 19040
    [No Abstract]   [Full Text] [Related]  

  • 2. Substrate and inhibitor complexes of dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Arch Biochem Biophys; 1975 Dec; 171(2):435-43. PubMed ID: 959
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved purification of tetrahydrofolate dehydrogenase from L1210 leukemia by affinity chromatography.
    Chello PL; Cashmore AR; Jacobs SA; Bertino JR
    Biochim Biophys Acta; 1972 Apr; 268(1):30-4. PubMed ID: 5018279
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification of tetrahydrofolate dehydrogenase by affinity chromatography.
    Gauldie J; Hillcoat BL
    Biochim Biophys Acta; 1972 Apr; 268(1):35-40. PubMed ID: 4401610
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic heterogeneity of dihydrofolate reductase from methotrexate sensitive and resistant L1210 leukemia cells.
    Iqbal MP; Rothenberg SP; Larosa C
    Proc Soc Exp Biol Med; 1985 Oct; 180(1):98-102. PubMed ID: 2412235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple forms of L1210 dihydrofolate reductase differing in affinity for methotrexate.
    Duffy TH; Beckman SB; Huennekens FM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):352-8. PubMed ID: 6704125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrofolate reductase from a resistant subline of the L1210 lymphoma. Purification and properties.
    Perkins JP; Hillcoat BL; Bertino JR
    J Biol Chem; 1967 Oct; 242(20):4771-6. PubMed ID: 4964810
    [No Abstract]   [Full Text] [Related]  

  • 8. Circular dichroism studies of dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli.
    Greenfield NJ; Williams MN; Poe M; Hoogsteen K
    Biochemistry; 1972 Dec; 11(25):4706-11. PubMed ID: 4144060
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydrofolate reductase activity and loss of resistance in an antifolate-resistant subline of leukemia L1210 after discontinuation of treatment.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Chem Biol Interact; 1970 Oct; 2(3):229-34. PubMed ID: 5289825
    [No Abstract]   [Full Text] [Related]  

  • 10. Folate antagonists covalently linked to carbohydrates: synthesis, properties, and use in the purification of dihydrofolate reductases.
    Whiteley JM; Jackson RC; Mell GP; Drais JH; Huennekens FM
    Arch Biochem Biophys; 1972 May; 150(1):15-22. PubMed ID: 4623864
    [No Abstract]   [Full Text] [Related]  

  • 11. Turnover of dihydrofolate reductase in rapidly dividing cells.
    Jackson RC; Huennekens FM
    Arch Biochem Biophys; 1973 Jan; 154(1):192-8. PubMed ID: 4144053
    [No Abstract]   [Full Text] [Related]  

  • 12. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
    Bertino JR; Cashmore AR; Hillcoat BL
    Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of chicken liver dihydrofolate reductase after purification by affinity chromatography and isoelectric focusing.
    Kaufman BT; Kemerer VF
    Arch Biochem Biophys; 1977 Mar; 179(2):420-31. PubMed ID: 15516
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
    Dicker AP; Waltham MC; Volkenandt M; Schweitzer BI; Otter GM; Schmid FA; Sirotnak FM; Bertino JR
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11797-801. PubMed ID: 8265628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of N-bromosuccinimide modification on dihydrofolate reductase from a methotrexate-resistant strain of Escherichia coli. Activity, spectrophotometric, fluorescence and circular dichroism studies.
    Williams MN
    J Biol Chem; 1975 Jan; 250(1):322-30. PubMed ID: 237891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydrofolate reductase activity of leukemia L1210 during development of methotrexate resistance.
    Schrecker AW; Mead JA; Greenberg NH; Goldin A
    Biochem Pharmacol; 1971 Mar; 20(3):716-8. PubMed ID: 5150168
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydrofolate reductase from mouse liver and spleen. Purification, properties and inhibition by substituted 2,4-diaminopyrimidines and 4,6-diaminotriazines.
    McCullough JL; Bertino JR
    Biochem Pharmacol; 1971 Mar; 20(3):561-74. PubMed ID: 4402459
    [No Abstract]   [Full Text] [Related]  

  • 18. Preparation of (-)-5,6,7,8-tetrahydrofolate using immobilized dihydrofolate reductase.
    Ahmed F; Dunlap RB
    Anal Biochem; 1984 Aug; 141(1):149-54. PubMed ID: 6496924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The isolation of dihydrofolate reductases by affinity chromatography on folate-sepharose.
    Whiteley JM; Henderson GB; Russell A; Singh P; Zevely EM
    Anal Biochem; 1977 May; 79(1-2):42-51. PubMed ID: 405885
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of 1,N6-ethenoadenine derivatives of triphosphopyridine and reduced triphosphopyridine nucleotides with dihydrofolate reductase from amethopterin-resistant L1210 cells.
    Neef VG; Huennekens FM
    Biochemistry; 1976 Sep; 15(18):4042-7. PubMed ID: 9129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.